All Stories

  1. Faculty Opinions recommendation of Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A.

    Article • October 2014, F1000Research

    Professor Gili Kenet

  2. Faculty Opinions recommendation of Advances in bypassing agent therapy for hemophilia patients with inhibitors to close care gaps and improve outcomes.

    Article • August 2014, F1000Research

    Professor Gili Kenet

  3. Clinical and laboratory characteristics of children with venous thromboembolism and protein C‐deficiency: an observational Israeli‐German cohort study

    Article • British Journal of Haematology, July 2014, Wiley

    Professor Gili Kenet

  4. Faculty Opinions recommendation of Effect of von Willebrand factor on inhibitor eradication in patients with severe haemophilia A: a systematic review.

    Article • June 2014, F1000Research

    Professor Gili Kenet

  5. Faculty Opinions recommendation of Omental implantation of BOECs in hemophilia dogs results in circulating FVIII antigen and a complex immune response.

    Article • May 2014, F1000Research

    Professor Gili Kenet

  6. Influence of factor 5 rs6025 and factor 2 rs1799963 mutation on inhibitor development in patients with hemophilia A - an Israeli-German multicenter database study

    Article • Thrombosis Research, April 2014, Elsevier

    Professor Gili Kenet

  7. Chitosan-based Dressing for the Treatment of External/Accessible Bleedings in Children With Bleeding Tendency

    Article • Journal of Pediatric Hematology/Oncology, March 2014, Wolters Kluwer Health

    Professor Gili Kenet

  8. Challenging Aspects of Managing Hemostasis in Adolescents

    Article • Acta Haematologica, January 2014, Karger Publishers

    Professor Gili Kenet

  9. 561: Fetal thrombophilia in intrauterine fetal death

    Article • American Journal of Obstetrics and Gynecology, January 2014, Elsevier

    Professor Gili Kenet

  10. Faculty Opinions recommendation of FXIII: mechanisms of action in the treatment of hemophilia A.

    Article • December 2013, F1000Research

    Professor Gili Kenet

  11. Author's reply to: Al-Abdi SY. Virus-inactivated plasma and intraventricular hemorrhage in preterm neonates

    Article • The Journal of Maternal-Fetal & Neonatal Medicine, November 2013, Taylor & Francis

    Professor Gili Kenet

  12. Surfactant impairs coagulation in-vitro: A risk factor for pulmonary hemorrhage?

    Article • Thrombosis Research, November 2013, Elsevier

    Professor Gili Kenet

  13. Faculty Opinions recommendation of Anticoagulant treatment with rivaroxaban in severe protein S deficiency.

    Article • October 2013, F1000Research

    Professor Gili Kenet

  14. Intraventricular haemorrhage in preterm infants – Can we improve outcome by addressing coagulation?

    Article • The Journal of Maternal-Fetal & Neonatal Medicine, August 2013, Taylor & Francis

    Professor Gili Kenet

  15. Faculty Opinions recommendation of Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s.

    Article • June 2013, F1000Research

    Professor Gili Kenet

  16. Faculty Opinions recommendation of Familial risk of venous thromboembolism in first-, second- and third-degree relatives: a nationwide family study in Sweden.

    Article • March 2013, F1000Research

    Professor Gili Kenet

  17. Faculty Opinions recommendation of Factor VIII products and inhibitor development in severe hemophilia A.

    Article • January 2013, F1000Research

    Professor Gili Kenet

  18. Factor VIII Products and Inhibitor Development in Severe Hemophilia A

    Article • New England Journal of Medicine, January 2013, New England Journal of Medicine (NEJM/MMS)

    Professor Gili Kenet

  19. Intraventricular hemorrhage in preterm infants and coagulation – Ambivalent perspectives?

    Article • Thrombosis Research, January 2013, Elsevier

    Professor Gili Kenet

  20. Venous thromboembolism in neonates and children – Update 2013

    Article • Thrombosis Research, January 2013, Elsevier

    Professor Gili Kenet

  21. Risk Factors for High-Titer Inhibitor Development in Children with Hemophilia A: Results of a Cohort Study

    Article • BioMed Research International, January 2013, Hindawi Publishing Corporation

    Professor Gili Kenet

  22. Role of reduced ADAMTS13 in arterial ischemic stroke: A Pediatric Cohort Study

    Article • Annals of Neurology, December 2012, Wiley

    Professor Gili Kenet

  23. Faculty Opinions recommendation of An observational, prospective, two-cohort comparison of a fixed versus variable dosing strategy of prothrombin complex concentrate to counteract vitamin K antagonists in 240 bleeding emergencies.

    Article • October 2012, F1000Research

    Professor Gili Kenet

  24. Faculty Opinions recommendation of Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.

    Article • October 2012, F1000Research

    Professor Gili Kenet

  25. The impact of genetic and environmental factors on homocysteine levels in preterm neonates

    Article • Pediatric Blood & Cancer, September 2012, Wiley

    Professor Gili Kenet

  26. Venous thromboembolism in neonates and children

    Article • Best Practice & Research Clinical Haematology, September 2012, Elsevier

    Professor Gili Kenet

  27. Difficult clinical challenges in haemophilia: international experiential perspectives

    Article • Haemophilia, July 2012, Wiley

    Professor Gili Kenet, Professor Paul Knoebl

  28. Faculty Opinions recommendation of Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers.

    Article • June 2012, F1000Research

    Professor Gili Kenet

  29. Fibrinoid reaction after lens extraction in rabbit eyes

    Article • Journal of Cataract & Refractive Surgery, May 2012, Wolters Kluwer Health

    Professor Gili Kenet

  30. Faculty Opinions recommendation of The principal results of the International Immune Tolerance Study: a randomized dose comparison.

    Article • March 2012, F1000Research

    Professor Gili Kenet

  31. Faculty Opinions recommendation of A highly sensitive thrombin generation assay for assessment of recombinant activated factor VII therapy in haemophilia patients with an inhibitor.

    Article • January 2012, F1000Research

    Professor Gili Kenet

  32. Faculty Opinions recommendation of Adenovirus-associated virus vector-mediated gene transfer in hemophilia B.

    Article • January 2012, F1000Research

    Professor Gili Kenet

  33. Thrombophilia testing in neonates and infants with thrombosis

    Article • Seminars in Fetal and Neonatal Medicine, December 2011, Elsevier

    Professor Gili Kenet

  34. Severe factor X deficiency in three unrelated Palestinian patients is caused by homozygosity for the mutation c302delG-correlation with thrombin generation and thromboelastometry

    Article • Blood Coagulation & Fibrinolysis, December 2011, Wolters Kluwer Health

    Professor Gili Kenet

  35. Faculty Opinions recommendation of Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors.

    Article • November 2011, F1000Research

    Professor Gili Kenet

  36. Intraventricular Hemorrhage in Preterm Infants: Coagulation Perspectives

    Article • Seminars in Thrombosis and Hemostasis, October 2011, Thieme Publishing Group

    Professor Gili Kenet

  37. Hemostasis and Thrombosis in Pediatric Patients: Special Issues and Unique Concerns

    Article • Seminars in Thrombosis and Hemostasis, October 2011, Thieme Publishing Group

    Professor Gili Kenet

  38. Safety and Efficacy of Low Molecular Weight Heparins in Children: A Systematic Review of the Literature and Meta-Analysis of Single-Arm Studies

    Article • Seminars in Thrombosis and Hemostasis, October 2011, Thieme Publishing Group

    Professor Gili Kenet

  39. Impact of Persistent Antiphospholipid Antibodies on Risk of Incident Symptomatic Thromboembolism in Children: A Systematic Review and Meta-Analysis

    Article • Seminars in Thrombosis and Hemostasis, October 2011, Thieme Publishing Group

    Professor Gili Kenet

  40. Restrictive Management of Neonatal Polycythemia

    Article • American Journal of Perinatology, June 2011, Thieme Publishing Group

    Professor Gili Kenet

  41. Neonatal IVH – mechanisms and management

    Article • Thrombosis Research, February 2011, Elsevier

    Professor Gili Kenet

  42. Point of care testing in children undergoing cardiopulmonary bypass

    Article • Pediatric Blood & Cancer, December 2010, Wiley

    Professor Gili Kenet

  43. Thrombosis in children and neonates

    Article • Thrombosis Research, December 2010, Elsevier

    Professor Gili Kenet

  44. Predictors for neonatal thrombocytopenia in infants of thrombocytopenic mothers during pregnancy

    Article • Pediatric Blood & Cancer, March 2010, Wiley

    Professor Gili Kenet

  45. Storage of Blood Components Does Not Decrease Haemostatic Potential: In vitro Assessment of Fresh versus Stored Blood Components Using Thromboelastography

    Article • Transfusion Medicine and Hemotherapy, January 2010, Karger Publishers

    Professor Gili Kenet

  46. Role of endogenous testosterone concentration in pediatric stroke

    Article • Annals of Neurology, December 2009, Wiley

    Professor Gili Kenet

  47. Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatment

    Article • Best Practice & Research Clinical Haematology, March 2009, Elsevier

    Professor Gili Kenet

  48. Activated protein C concentrate treatment for skin necrosis under warfarin treatment in severe genetic protein C deficiency combined with prothrombin mutation and factor V Leiden

    Article • Thrombosis and Haemostasis, January 2009, Schattauer GmbH

    Professor Gili Kenet

  49. Bleeding issues in neonates, infants and young children

    Article • Thrombosis Research, January 2009, Elsevier

    Professor Gili Kenet

  50. Hemostasis and Thrombosis in Critically Ill Children

    Article • Seminars in Thrombosis and Hemostasis, July 2008, Thieme Publishing Group

    Professor Gili Kenet

  51. Single-Dose Recombinant Activated Factor VII Therapy in Hemophilia Patients With Inhibitors

    Article • Seminars in Hematology, April 2008, Elsevier

    Professor Gili Kenet

  52. WITHDRAWN: Pediatric antiphospholipid syndrome

    Article • Autoimmunity Reviews, November 2007, Elsevier

    Professor Gili Kenet

  53. Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study

    Article • The Lancet Neurology, July 2007, Elsevier

    Professor Gili Kenet

  54. Perinatal ischemic stroke and the incidence of maternal and neonatal thrombophilia

    Article • American Journal of Obstetrics and Gynecology, December 2006, Elsevier

    Professor Gili Kenet

  55. Fetal and Neonatal Thrombophilia

    Article • Obstetrics and Gynecology Clinics of North America, September 2006, Elsevier

    Professor Gili Kenet

  56. Home treatment of haemarthroses using a single dose regimen of recombinant activated FVII in patients with haemophilia and inhibitors. A multi-centre, randomised, double-blind, cross-over trial

    Article • Thrombosis and Haemostasis, March 2006, Schattauer GmbH

    Professor Gili Kenet

  57. High-Dose Recombinant Factor VIIa Therapy in Hemophilia Patients With Inhibitors

    Article • Seminars in Hematology, January 2006, Elsevier

    Professor Gili Kenet

  58. Thrombophilia in children with venous thromboembolic disease

    Article • Thrombosis Research, January 2006, Elsevier

    Professor Gili Kenet

  59. Bleeding and Thrombosis Issues in Pediatric Patients: Current Approach to Diagnosis and Treatment

    Article • Acta Haematologica, January 2006, Karger Publishers

    Professor Gili Kenet

  60. Role of thrombophilic risk factors in children with non-stroke cerebral palsy

    Article • Thrombosis Research, January 2005, Elsevier

    Professor Gili Kenet

  61. Thrombophilia and pregnancy complications

    Article • Thrombosis and Haemostasis, August 2004, Schattauer GmbH

    Professor Gili Kenet

  62. Paedritic cerebral sinus vein thrombosis: A multi-center, case-controlled study

    Article • Thrombosis and Haemostasis, August 2004, Schattauer GmbH

    Professor Gili Kenet

  63. The Use of Recombinant Factor VIIa for Hemorrhage Control in Trauma Patients

    Article • Transfusion Alternatives in Transfusion Medicine, December 2003, Wiley

    Professor Gili Kenet

  64. Recombinant activated factor VII for life-threatening pulmonary hemorrhage after pediatric cardiac surgery

    Article • Pediatric Critical Care Medicine, October 2003, Wolters Kluwer Health

    Professor Gili Kenet

  65. Thrombophilia does not increase risk for neonatal complications in preterm infants

    Article • Thrombosis and Haemostasis, September 2003, Schattauer GmbH

    Professor Gili Kenet

  66. Recombinant Factor VIIa for Treatment of a Child With Severe Factor VII Deficiency and Coarctation of the Aorta

    Article • Journal of Pediatric Hematology/Oncology, July 2003, Wolters Kluwer Health

    Professor Gili Kenet

  67. Recombinant Activated Factor VII for Adjunctive Hemorrhage Control in Trauma*

    Article • Transfusion Alternatives in Transfusion Medicine, October 2001, Wiley

    Professor Gili Kenet

  68. Recombinant Activated Factor VII for Adjunctive Hemorrhage Control in Trauma

    Article • Journal of Trauma and Acute Care Surgery, September 2001, Wolters Kluwer Health

    Professor Gili Kenet

  69. RISK STRATIFICATION

    Article • Dermatologic Clinics, April 2001, Elsevier

    Professor Gili Kenet

  70. Treatment of traumatic bleeding with recombinant factor VIIa

    Article • The Lancet, November 1999, Elsevier

    Professor Gili Kenet

  71. Association between hyperflexibility of the thumb and an unexplained bleeding tendency: is it a rule of thumb?

    Article • British Journal of Haematology, May 1998, Wiley

    Professor Gili Kenet

  72. Chromosomal Translocation (1

    Article • Journal of Pediatric Hematology/Oncology, January 1998, Wolters Kluwer Health

    Professor Gili Kenet

  73. Desmoplastic Infantile Ganglioglioma

    Article • Acta Oncologica, January 1997, Taylor & Francis

    Professor Gili Kenet

  74. Helicobacter Pylori-Assoclated Gastric Lymphoma in a Girl

    Article • Pediatric Hematology and Oncology, January 1997, Taylor & Francis

    Professor Gili Kenet

  75. Two embryonal cancers after in vitro fertilization

    Article • Cancer, December 1995, Wiley

    Professor Gili Kenet

  76. Melanoma screening with digital epiluminescence microscopy

    Article • Melanoma Research, March 1993, Wolters Kluwer Health

    Professor Gili Kenet

  77. Infantile Idiopathic Thrombocytopenic Purpura

    Article • Pediatric Hematology and Oncology, January 1990, Taylor & Francis

    Professor Gili Kenet

  78. Bleeding disorders in neonates

    Article • Taylor & Francis

    Professor Gili Kenet